These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37662363)

  • 1. The resting and ligand-bound states of the membrane-embedded human T-cell receptor-CD3 complex.
    Notti RQ; Yi F; Heissel S; Bush MW; Molvi Z; Das P; Molina H; Klebanoff CA; Walz T
    bioRxiv; 2024 Sep; ():. PubMed ID: 37662363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites.
    Rangarajan S; He Y; Chen Y; Kerzic MC; Ma B; Gowthaman R; Pierce BG; Nussinov R; Mariuzza RA; Orban J
    J Biol Chem; 2018 Oct; 293(41):15991-16005. PubMed ID: 30135211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States.
    Alba J; D'Abramo M
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-scale simulations of the T cell receptor reveal its lipid interactions, dynamics and the arrangement of its cytoplasmic region.
    Prakaash D; Cook GP; Acuto O; Kalli AC
    PLoS Comput Biol; 2021 Jul; 17(7):e1009232. PubMed ID: 34280187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical differences in the alphabeta T cell receptor.CD3 surface complex between CD8+ and CD4+ human mature T lymphocytes.
    Zapata DA; Schamel WW; Torres PS; Alarcón B; Rossi NE; Navarro MN; Toribio ML; Regueiro JR
    J Biol Chem; 2004 Jun; 279(23):24485-92. PubMed ID: 15060077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of human γδ T cell receptor-CD3 complex.
    Xin W; Huang B; Chi X; Liu Y; Xu M; Zhang Y; Li X; Su Q; Zhou Q
    Nature; 2024 Jun; 630(8015):222-229. PubMed ID: 38657677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility.
    Chen Y; Zhu Y; Li X; Gao W; Zhen Z; Dong D; Huang B; Ma Z; Zhang A; Song X; Ma Y; Guo C; Zhang F; Huang Z
    Mol Cell; 2022 Apr; 82(7):1278-1287.e5. PubMed ID: 35271814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of assembly of the human T cell receptor-CD3 complex.
    Dong D; Zheng L; Lin J; Zhang B; Zhu Y; Li N; Xie S; Wang Y; Gao N; Huang Z
    Nature; 2019 Sep; 573(7775):546-552. PubMed ID: 31461748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular architecture of the αβ T cell receptor-CD3 complex.
    Birnbaum ME; Berry R; Hsiao YS; Chen Z; Shingu-Vazquez MA; Yu X; Waghray D; Fischer S; McCluskey J; Rossjohn J; Walz T; Garcia KC
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17576-81. PubMed ID: 25422432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a fully assembled tumor-specific T cell receptor ligated by pMHC.
    Sušac L; Vuong MT; Thomas C; von Bülow S; O'Brien-Ball C; Santos AM; Fernandes RA; Hummer G; Tampé R; Davis SJ
    Cell; 2022 Aug; 185(17):3201-3213.e19. PubMed ID: 35985289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does T cell receptor clustering impact on signal transduction?
    Goyette J; Nieves DJ; Ma Y; Gaus K
    J Cell Sci; 2019 Feb; 132(4):. PubMed ID: 30745330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
    Mariuzza RA; Agnihotri P; Orban J
    J Biol Chem; 2020 Jan; 295(4):914-925. PubMed ID: 31848223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural variability and concerted motions of the T cell receptor - CD3 complex.
    Pandey PR; Różycki B; Lipowsky R; Weikl TR
    Elife; 2021 Sep; 10():. PubMed ID: 34490842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments.
    Brazin KN; Mallis RJ; Li C; Keskin DB; Arthanari H; Gao Y; Wu SL; Karger BL; Wagner G; Reinherz EL
    J Biol Chem; 2014 Jul; 289(27):18880-92. PubMed ID: 24849600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Dynamics Simulations Reveal Canonical Conformations in Different pMHC/TCR Interactions.
    Alba J; Rienzo LD; Milanetti E; Acuto O; D'Abramo M
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric changes in the TCR/CD3 structure upon interaction with extra- or intra-cellular ligands.
    Rubin B; Knibiehler M; Gairin JE
    Scand J Immunol; 2007; 66(2-3):228-37. PubMed ID: 17635800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in arrangement and in conformation of molecular components of peripheral T-cell antigen receptor complex after ligand binding: analyses by co-precipitation profiles.
    Osono E; Sato N; Yokomuro K; Saizawa MK
    Scand J Immunol; 1997 May; 45(5):487-93. PubMed ID: 9160091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).
    He Y; Agnihotri P; Rangarajan S; Chen Y; Kerzic MC; Ma B; Nussinov R; Mariuzza RA; Orban J
    J Mol Biol; 2020 Dec; 432(24):166697. PubMed ID: 33157083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.